Rtw Investments, LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
68
Total Value
6538371722
Accession Number
0001493215-25-000003
Form Type
13F-HR
Manager Name
Rtw Investments, LP
Data Enrichment
93% identified
63 identified5 unidentified

Holdings

68 positions
Manager:
Search and click to pin securities to the top
Page 3 of 4
ARVINAS, INC.
Shares:
3334308(+0.0%)
Value:
$23.4B(-63.4%)
LENZ Therapeutics, Inc.
Shares:
863389(+0.0%)
Value:
$22.2B(-10.9%)
Replimune Group, Inc.
Shares:
2065010(+0.0%)
Value:
$20.1B(-19.5%)
Oruka Therapeutics, Inc.
Shares:
1945649(+0.0%)
Value:
$20.0B(-47.1%)
Tempus AI, Inc.
Shares:
400000
Value:
$19.3B
GLAUKOS Corp
Shares:
190000
Value:
$18.7B
Dyne Therapeutics, Inc.
Shares:
1690567(-67.6%)
Value:
$17.7B(-85.6%)
CARGO Therapeutics, Inc.
Shares:
4124859(+0.0%)
Value:
$16.8B(-71.8%)
QUEST DIAGNOSTICS INC
Shares:
98997
Value:
$16.8B
COMPASS Pathways plc
Shares:
5538168(+78.7%)
Value:
$15.8B(+35.2%)
Neurogene Inc.
Shares:
1348656(-0.1%)
Value:
$15.8B(-48.8%)
RAPT Therapeutics, Inc.
Shares:
11764000(+0.0%)
Value:
$14.4B(-22.8%)
89bio, Inc.
Shares:
1967527(-73.7%)
Value:
$14.3B(-75.5%)
Cullinan Therapeutics, Inc.
Shares:
1705960(+0.0%)
Value:
$12.9B(-37.8%)
Beam Therapeutics Inc.
Shares:
438659
Value:
$8.6B
Corvus Pharmaceuticals, Inc.
Shares:
2679479(+0.0%)
Value:
$8.5B(-40.6%)
G70077105
Shares:
742500(+0.0%)
Value:
$7.6B(+1.2%)
Wave Life Sciences Ltd.
Shares:
900000(+0.0%)
Value:
$7.3B(-34.7%)
EXAGEN INC.
Shares:
1511866(+0.0%)
Value:
$5.4B(-12.4%)
G52441105
Shares:
200000
Value:
$5.0B